Establishment Labs (ESTA) Stock Forecast, Price Target & Predictions
ESTA Stock Forecast
Establishment Labs stock forecast is as follows: an average price target of $78.00 (represents a 86.56% upside from ESTA’s last price of $41.81) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
ESTA Price Target
ESTA Analyst Ratings
Buy
Establishment Labs Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 22, 2024 | Joanne Wuensch | Citigroup | $45.00 | $44.05 | 2.16% | 7.63% |
Jun 06, 2024 | Anthony Petrone | Mizuho Securities | $70.00 | $53.89 | 29.89% | 67.42% |
Apr 01, 2024 | Anthony Petrone | Mizuho Securities | $65.00 | $50.90 | 27.70% | 55.47% |
Dec 28, 2022 | - | Stephens | $87.00 | $60.45 | 43.92% | 108.08% |
Apr 22, 2022 | - | BTIG | $110.00 | $81.89 | 34.33% | 163.09% |
10
Establishment Labs Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 3 |
Avg Price Target | - | $45.00 | $60.00 |
Last Closing Price | $41.81 | $41.81 | $41.81 |
Upside/Downside | -100.00% | 7.63% | 43.51% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 14, 2024 | Cowen & Co. | Buy | Buy | Hold |
Oct 01, 2024 | Stephens | Neutral | Neutral | Hold |
Oct 01, 2024 | Citigroup | Underperform | Underperform | Hold |
Aug 22, 2024 | Citigroup | Underperform | Underperform | Hold |
Aug 22, 2024 | Stephens | Buy | Buy | Hold |
Aug 22, 2024 | Citigroup | Neutral | Neutral | Hold |
Jul 10, 2024 | Citigroup | Neutral | Neutral | Hold |
May 22, 2024 | Cowen & Co. | Buy | Buy | Hold |
May 22, 2024 | Citigroup | Buy | Neutral | Downgrade |
Apr 15, 2024 | BTIG | Buy | Buy | Hold |
10
Establishment Labs Financial Forecast
Establishment Labs Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $31.56M | $38.51M | $48.56M | $46.52M | $43.81M | $38.24M | $41.19M | $38.45M | $35.31M | $29.04M | $31.99M | $30.34M | $26.96M | $22.76M | $10.47M | $24.48M | $24.25M | $22.85M |
Avg Forecast | $70.40M | $64.42M | $63.80M | $56.89M | $58.76M | $52.32M | $52.78M | $43.92M | $44.68M | $40.45M | $43.10M | $35.61M | $31.44M | $40.48M | $47.36M | $45.45M | $43.26M | $37.32M | $38.39M | $35.25M | $34.85M | $27.97M | $29.79M | $25.31M | $25.27M | $19.67M | $12.50M | $23.38M | $22.21M | $19.43M |
High Forecast | $74.57M | $68.23M | $67.58M | $60.26M | $62.24M | $55.42M | $55.91M | $46.70M | $48.01M | $40.50M | $43.10M | $35.61M | $31.62M | $40.48M | $50.17M | $48.14M | $45.82M | $37.32M | $38.39M | $35.25M | $34.85M | $27.97M | $29.79M | $25.31M | $25.27M | $19.67M | $12.50M | $23.38M | $22.21M | $19.43M |
Low Forecast | $67.08M | $61.38M | $60.79M | $54.21M | $55.99M | $49.85M | $50.29M | $42.31M | $41.35M | $40.40M | $43.10M | $35.61M | $31.21M | $40.48M | $45.13M | $43.31M | $41.22M | $37.32M | $38.39M | $35.25M | $34.85M | $27.97M | $29.79M | $25.31M | $25.27M | $19.67M | $12.50M | $23.38M | $22.21M | $19.43M |
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.95% | 1.03% | 1.02% | 1.01% | 1.02% | 1.07% | 1.09% | 1.01% | 1.04% | 1.07% | 1.20% | 1.07% | 1.16% | 0.84% | 1.05% | 1.09% | 1.18% |
Forecast
Establishment Labs EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-22.11M | $-21.04M | $-12.20M | $-7.36M | $-10.54M | $-14.13M | $-15.23M | $-2.85M | $-31.43M | $-11.27M | $-1.63M | $-3.58M | $-2.73M | $-307.00K | $-7.35M | $-14.55M | $-2.10M | $-9.87M |
Avg Forecast | $-21.03M | $-19.24M | $-19.06M | $-17.00M | $-17.55M | $-15.63M | $-15.77M | $-13.12M | $-13.35M | $-12.08M | $-12.88M | $-10.64M | $-9.39M | $-12.09M | $-14.15M | $-13.58M | $-12.92M | $-11.92M | $-12.26M | $-3.00M | $-11.13M | $-8.93M | $-9.51M | $-4.11M | $-8.07M | $-6.28M | $-3.99M | $-8.78M | $-7.09M | $-6.20M |
High Forecast | $-20.04M | $-18.34M | $-18.16M | $-16.20M | $-16.73M | $-14.89M | $-15.03M | $-12.64M | $-12.35M | $-12.07M | $-12.88M | $-10.64M | $-9.32M | $-12.09M | $-13.48M | $-12.94M | $-12.31M | $-11.92M | $-12.26M | $-2.40M | $-11.13M | $-8.93M | $-9.51M | $-3.28M | $-8.07M | $-6.28M | $-3.99M | $-7.02M | $-7.09M | $-6.20M |
Low Forecast | $-22.28M | $-20.39M | $-20.19M | $-18.00M | $-18.59M | $-16.56M | $-16.70M | $-13.95M | $-14.34M | $-12.10M | $-12.88M | $-10.64M | $-9.45M | $-12.09M | $-14.99M | $-14.38M | $-13.69M | $-11.92M | $-12.26M | $-3.60M | $-11.13M | $-8.93M | $-9.51M | $-4.93M | $-8.07M | $-6.28M | $-3.99M | $-10.53M | $-7.09M | $-6.20M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.35% | 1.74% | 0.86% | 0.54% | 0.82% | 1.19% | 1.24% | 0.95% | 2.82% | 1.26% | 0.17% | 0.87% | 0.34% | 0.05% | 1.84% | 1.66% | 0.30% | 1.59% |
Forecast
Establishment Labs Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-20.54M | $-29.27M | $-16.75M | $-11.94M | $-13.56M | $-18.61M | $-37.11M | $-5.93M | $-11.34M | $-14.68M | $-5.32M | $-6.95M | $-5.64M | $-4.25M | $-10.47M | $-17.76M | $-5.56M | $-12.78M |
Avg Forecast | $-8.21M | $-12.00M | $-12.27M | $-15.86M | $-9.49M | $-13.89M | $-13.88M | $-15.29M | $-17.89M | $-17.16M | $-14.32M | $-18.64M | $-25.45M | $-22.37M | $-19.97M | $-18.97M | $-18.93M | $-15.90M | $-11.12M | $-8.12M | $-9.27M | $-10.17M | $-7.83M | $-7.97M | $-5.27M | $-9.59M | $-12.65M | $-10.71M | $-16.33M | $-14.09M |
High Forecast | $-7.70M | $-11.27M | $-11.52M | $-14.88M | $-8.91M | $-13.04M | $-13.03M | $-14.35M | $-13.98M | $-16.11M | $-13.44M | $-17.50M | $-24.11M | $-21.00M | $-18.75M | $-17.81M | $-17.77M | $-15.90M | $-11.12M | $-6.50M | $-9.27M | $-10.17M | $-7.83M | $-6.38M | $-5.27M | $-9.59M | $-12.65M | $-8.57M | $-16.33M | $-14.09M |
Low Forecast | $-8.84M | $-12.93M | $-13.22M | $-17.08M | $-10.22M | $-14.96M | $-14.95M | $-16.46M | $-20.97M | $-18.48M | $-15.42M | $-20.07M | $-27.59M | $-24.10M | $-21.51M | $-20.43M | $-20.39M | $-15.90M | $-11.12M | $-9.74M | $-9.27M | $-10.17M | $-7.83M | $-9.56M | $-5.27M | $-9.59M | $-12.65M | $-12.86M | $-16.33M | $-14.09M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.81% | 1.31% | 0.84% | 0.63% | 0.72% | 1.17% | 3.34% | 0.73% | 1.22% | 1.44% | 0.68% | 0.87% | 1.07% | 0.44% | 0.83% | 1.66% | 0.34% | 0.91% |
Forecast
Establishment Labs SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $36.88M | $39.96M | $37.03M | $31.71M | $34.85M | $31.27M | $32.96M | $26.91M | $27.56M | $24.78M | $21.75M | $18.14M | $18.20M | $15.01M | $14.44M | $18.98M | $17.13M | $19.23M |
Avg Forecast | $55.84M | $51.10M | $50.60M | $45.13M | $46.61M | $41.50M | $41.87M | $34.84M | $35.44M | $32.08M | $34.19M | $28.25M | $24.94M | $32.11M | $37.57M | $36.05M | $34.31M | $29.61M | $30.46M | $27.96M | $27.65M | $22.19M | $23.63M | $20.81M | $20.04M | $15.60M | $9.91M | $11.45M | $17.62M | $15.41M |
High Forecast | $59.15M | $54.12M | $53.60M | $47.80M | $49.37M | $43.96M | $44.35M | $37.04M | $38.08M | $32.12M | $34.19M | $28.25M | $25.08M | $32.11M | $39.79M | $38.19M | $36.35M | $29.61M | $30.46M | $27.96M | $27.65M | $22.19M | $23.63M | $24.97M | $20.04M | $15.60M | $9.91M | $13.74M | $17.62M | $15.41M |
Low Forecast | $53.21M | $48.69M | $48.22M | $43.00M | $44.41M | $39.54M | $39.89M | $33.56M | $32.80M | $32.05M | $34.19M | $28.25M | $24.75M | $32.11M | $35.80M | $34.35M | $32.70M | $29.61M | $30.46M | $27.96M | $27.65M | $22.19M | $23.63M | $16.64M | $20.04M | $15.60M | $9.91M | $9.16M | $17.62M | $15.41M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.48% | 1.24% | 0.99% | 0.88% | 1.02% | 1.06% | 1.08% | 0.96% | 1.00% | 1.12% | 0.92% | 0.87% | 0.91% | 0.96% | 1.46% | 1.66% | 0.97% | 1.25% |
Forecast
Establishment Labs EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.79 | $-1.12 | $-0.65 | $-0.48 | $-0.55 | $-0.76 | $-1.52 | $-0.24 | $-0.47 | $-0.61 | $-0.22 | $-0.29 | $-0.24 | $-0.18 | $-0.45 | $-0.79 | $-0.27 | $-0.62 |
Avg Forecast | $-0.29 | $-0.43 | $-0.44 | $-0.57 | $-0.34 | $-0.50 | $-0.50 | $-0.55 | $-0.64 | $-0.61 | $-0.51 | $-0.67 | $-0.91 | $-0.80 | $-0.72 | $-0.68 | $-0.68 | $-0.57 | $-0.40 | $-0.38 | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.19 | $-0.34 | $-0.45 | $-0.32 | $-0.59 | $-0.51 |
High Forecast | $-0.28 | $-0.40 | $-0.41 | $-0.53 | $-0.32 | $-0.47 | $-0.47 | $-0.51 | $-0.50 | $-0.58 | $-0.48 | $-0.63 | $-0.86 | $-0.75 | $-0.67 | $-0.64 | $-0.64 | $-0.57 | $-0.40 | $-0.38 | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.19 | $-0.34 | $-0.45 | $-0.32 | $-0.59 | $-0.51 |
Low Forecast | $-0.32 | $-0.46 | $-0.47 | $-0.61 | $-0.37 | $-0.54 | $-0.54 | $-0.59 | $-0.75 | $-0.66 | $-0.55 | $-0.72 | $-0.99 | $-0.86 | $-0.77 | $-0.73 | $-0.73 | $-0.57 | $-0.40 | $-0.38 | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.19 | $-0.34 | $-0.45 | $-0.32 | $-0.59 | $-0.51 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.87% | 1.40% | 0.91% | 0.71% | 0.81% | 1.33% | 3.81% | 0.63% | 1.41% | 1.67% | 0.78% | 0.85% | 1.27% | 0.52% | 0.99% | 2.51% | 0.46% | 1.23% |
Forecast
Establishment Labs Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
APYX | Apyx Medical | $1.40 | $8.50 | 507.14% | Buy |
INGN | Inogen | $9.46 | $26.00 | 174.84% | Buy |
SGHT | Sight Sciences | $3.73 | $9.00 | 141.29% | Hold |
LUNG | Pulmonx | $6.20 | $11.93 | 92.42% | Buy |
ESTA | Establishment Labs | $41.81 | $78.00 | 86.56% | Buy |
KIDS | OrthoPediatrics | $25.50 | $39.60 | 55.29% | Buy |
LIVN | LivaNova | $50.05 | $70.50 | 40.86% | Buy |
NPCE | NeuroPace | $9.19 | $12.88 | 40.15% | Buy |
CNMD | CONMED | $70.69 | $96.00 | 35.80% | Buy |
FNA | Paragon 28 | $10.35 | $11.50 | 11.11% | Buy |
ITGR | Integer | $133.37 | $138.00 | 3.47% | Buy |
SRDX | Surmodics | $39.17 | $39.50 | 0.84% | Buy |
GKOS | Glaukos | $141.44 | $123.44 | -12.73% | Buy |